Aarkstore.com announces, The Latest market research report is available inits vast collection:Cancer Pain – Pipeline Revie...
Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Cancer Pain.- Ide...
List of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore....
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2...
Upcoming SlideShare
Loading in...5
×

Cancer pain – pipeline review, h2 2012

352

Published on

Aarkstore Enterprise-Cancer pain – pipeline review, h2 2012

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
352
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cancer pain – pipeline review, h2 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Cancer Pain – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Cancer Pain - Pipeline Review, H2 2012, provides anoverview of the indication’s therapeutic pipeline. This report provides informationon the therapeutic development for Cancer Pain, complete with latest updates, andspecial features on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Cancer Pain. Cancer Pain - PipelineReview, Half Year is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Cancer Pain.- A review of the Cancer Pain products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.
  2. 2. Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Cancer Pain.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 7List of Figures 8Introduction 9Global Markets Direct Report Coverage 9Cancer Pain Overview 10Therapeutics Development 11An Overview of Pipeline Products for Cancer Pain 11Cancer Pain Therapeutics under Development by Companies 13Cancer Pain Therapeutics under Investigation by Universities/Institutes 17Late Stage Products 18Comparative Analysis 18Mid Clinical Stage Products 19Comparative Analysis 19Early Clinical Stage Products 20Comparative Analysis 20Discovery and Pre-Clinical Stage Products 21Comparative Analysis 21Cancer Pain Therapeutics – Products under Development by Companies 22Cancer Pain Therapeutics – Products under Investigation by Universities/Institutes23Companies Involved in Cancer Pain Therapeutics Development 24Johnson & Johnson 24BioDelivery Sciences International, Inc. 25List of Figures
  3. 3. List of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Neutropenia – Pipeline Review, H2 2012Amyloidosis – Pipeline Review, H2 2012Human Papillomavirus Infections – Pipeline Review, H2 2012Cancer Pain – Pipeline Review, H2 2012Dengue – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012
  4. 4. Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×